vs
Nutex Health, Inc.（NUTX）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
Rapid7, Inc.的季度营收约是Nutex Health, Inc.的1.4倍（$217.4M vs $151.7M），Nutex Health, Inc.净利率更高（7.8% vs 1.4%，领先6.4%），Rapid7, Inc.同比增速更快（0.5% vs -41.1%），Nutex Health, Inc.自由现金流更多（$69.0M vs $36.4M），过去两年Nutex Health, Inc.的营收复合增速更高（50.0% vs 3.0%）
Nutex Health是一家总部位于美国得克萨斯州休斯敦的营利性医疗企业，核心业务为运营各类医疗机构，是美国本土医疗领域的专业运营机构，致力于为当地市场提供相关医疗服务与场地运营支持。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
NUTX vs RPD — 直观对比
营收规模更大
RPD
是对方的1.4倍
$151.7M
营收增速更快
RPD
高出41.6%
-41.1%
净利率更高
NUTX
高出6.4%
1.4%
自由现金流更多
NUTX
多$32.6M
$36.4M
两年增速更快
NUTX
近两年复合增速
3.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $151.7M | $217.4M |
| 净利润 | $11.8M | $3.1M |
| 毛利率 | 30.4% | 68.9% |
| 营业利润率 | 20.4% | 1.0% |
| 净利率 | 7.8% | 1.4% |
| 营收同比 | -41.1% | 0.5% |
| 净利润同比 | -80.8% | 44.1% |
| 每股收益（稀释后） | $2.34 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NUTXRPD
| Q4 25 | $151.7M | $217.4M | ||
| Q3 25 | $267.8M | $218.0M | ||
| Q2 25 | $244.0M | $214.2M | ||
| Q1 25 | $211.8M | $210.3M | ||
| Q4 24 | $257.6M | $216.3M | ||
| Q3 24 | $78.8M | $214.7M | ||
| Q2 24 | $76.1M | $208.0M | ||
| Q1 24 | $67.5M | $205.1M |
净利润NUTXRPD
| Q4 25 | $11.8M | $3.1M | ||
| Q3 25 | $55.4M | $9.8M | ||
| Q2 25 | $-17.7M | $8.3M | ||
| Q1 25 | $21.2M | $2.1M | ||
| Q4 24 | $61.6M | $2.2M | ||
| Q3 24 | $-8.8M | $15.4M | ||
| Q2 24 | $-364.0K | $6.5M | ||
| Q1 24 | $-364.0K | $1.4M |
毛利率NUTXRPD
| Q4 25 | 30.4% | 68.9% | ||
| Q3 25 | 57.8% | 70.2% | ||
| Q2 25 | 51.2% | 70.6% | ||
| Q1 25 | 55.9% | 71.7% | ||
| Q4 24 | 55.0% | 69.5% | ||
| Q3 24 | 27.8% | 70.6% | ||
| Q2 24 | 29.7% | 70.7% | ||
| Q1 24 | 15.1% | 70.3% |
营业利润率NUTXRPD
| Q4 25 | 20.4% | 1.0% | ||
| Q3 25 | 48.7% | 2.7% | ||
| Q2 25 | 13.8% | 1.6% | ||
| Q1 25 | 38.1% | -0.0% | ||
| Q4 24 | 44.4% | 3.4% | ||
| Q3 24 | 12.3% | 6.0% | ||
| Q2 24 | 7.0% | 2.5% | ||
| Q1 24 | 2.1% | 4.7% |
净利率NUTXRPD
| Q4 25 | 7.8% | 1.4% | ||
| Q3 25 | 20.7% | 4.5% | ||
| Q2 25 | -7.3% | 3.9% | ||
| Q1 25 | 10.0% | 1.0% | ||
| Q4 24 | 23.9% | 1.0% | ||
| Q3 24 | -11.2% | 7.2% | ||
| Q2 24 | -0.5% | 3.1% | ||
| Q1 24 | -0.5% | 0.7% |
每股收益（稀释后）NUTXRPD
| Q4 25 | $2.34 | $0.05 | ||
| Q3 25 | $7.76 | $0.15 | ||
| Q2 25 | $-2.95 | $0.13 | ||
| Q1 25 | $3.33 | $0.03 | ||
| Q4 24 | $11.56 | $0.08 | ||
| Q3 24 | $-1.72 | $0.21 | ||
| Q2 24 | $-0.07 | $0.09 | ||
| Q1 24 | $-0.08 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $185.6M | $474.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $329.4M | $154.7M |
| 总资产 | $918.5M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NUTXRPD
| Q4 25 | $185.6M | $474.7M | ||
| Q3 25 | $166.0M | $407.1M | ||
| Q2 25 | $96.7M | $511.7M | ||
| Q1 25 | $84.7M | $493.5M | ||
| Q4 24 | $40.6M | $521.7M | ||
| Q3 24 | $46.9M | $443.7M | ||
| Q2 24 | $40.8M | $442.6M | ||
| Q1 24 | $30.0M | $411.7M |
股东权益NUTXRPD
| Q4 25 | $329.4M | $154.7M | ||
| Q3 25 | $317.2M | $127.2M | ||
| Q2 25 | $235.3M | $90.4M | ||
| Q1 25 | $176.9M | $52.7M | ||
| Q4 24 | $132.4M | $17.7M | ||
| Q3 24 | $60.4M | $-5.1M | ||
| Q2 24 | $62.7M | $-52.6M | ||
| Q1 24 | $63.0M | $-86.4M |
总资产NUTXRPD
| Q4 25 | $918.5M | $1.7B | ||
| Q3 25 | $964.5M | $1.7B | ||
| Q2 25 | $841.0M | $1.6B | ||
| Q1 25 | $761.9M | $1.6B | ||
| Q4 24 | $655.3M | $1.7B | ||
| Q3 24 | $438.5M | $1.6B | ||
| Q2 24 | $422.4M | $1.5B | ||
| Q1 24 | $404.3M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $70.4M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | $69.0M | $36.4M |
| 自由现金流率自由现金流/营收 | 45.5% | 16.8% |
| 资本支出强度资本支出/营收 | 0.9% | 0.5% |
| 现金转化率经营现金流/净利润 | 5.95× | 12.01× |
| 过去12个月自由现金流最近4个季度 | $245.6M | $146.2M |
8季度趋势，按日历期对齐
经营现金流NUTXRPD
| Q4 25 | $70.4M | $37.6M | ||
| Q3 25 | $99.5M | $39.0M | ||
| Q2 25 | $27.3M | $47.5M | ||
| Q1 25 | $51.0M | $29.8M | ||
| Q4 24 | $54.0K | $63.8M | ||
| Q3 24 | $6.8M | $44.0M | ||
| Q2 24 | $13.3M | $32.9M | ||
| Q1 24 | $3.1M | $31.1M |
自由现金流NUTXRPD
| Q4 25 | $69.0M | $36.4M | ||
| Q3 25 | $99.2M | $34.8M | ||
| Q2 25 | $26.5M | $46.6M | ||
| Q1 25 | $50.9M | $28.4M | ||
| Q4 24 | $-341.0K | $62.6M | ||
| Q3 24 | $6.2M | $42.6M | ||
| Q2 24 | $12.7M | $32.6M | ||
| Q1 24 | $2.3M | $30.4M |
自由现金流率NUTXRPD
| Q4 25 | 45.5% | 16.8% | ||
| Q3 25 | 37.0% | 16.0% | ||
| Q2 25 | 10.9% | 21.8% | ||
| Q1 25 | 24.0% | 13.5% | ||
| Q4 24 | -0.1% | 28.9% | ||
| Q3 24 | 7.8% | 19.9% | ||
| Q2 24 | 16.7% | 15.7% | ||
| Q1 24 | 3.4% | 14.8% |
资本支出强度NUTXRPD
| Q4 25 | 0.9% | 0.5% | ||
| Q3 25 | 0.1% | 1.9% | ||
| Q2 25 | 0.3% | 0.4% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.2% | 0.5% | ||
| Q3 24 | 0.8% | 0.6% | ||
| Q2 24 | 0.7% | 0.1% | ||
| Q1 24 | 1.1% | 0.3% |
现金转化率NUTXRPD
| Q4 25 | 5.95× | 12.01× | ||
| Q3 25 | 1.80× | 3.97× | ||
| Q2 25 | — | 5.70× | ||
| Q1 25 | 2.40× | 14.14× | ||
| Q4 24 | 0.00× | 29.36× | ||
| Q3 24 | — | 2.85× | ||
| Q2 24 | — | 5.03× | ||
| Q1 24 | — | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
